Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece

Group B streptococcus (GBS) remains a leading cause of neonatal disease. However, GBS rates and prevention strategies vary considerably worldwide. Herein, we investigated the burden and epidemiological trends of neonatal GBS infections in our area (Greece) over the last two decades. We conducted a m...

Full description

Bibliographic Details
Main Authors: Eleni Vergadi, Antonia Manoura, Emmanouil Chatzakis, Emmanouil Karavitakis, Sofia Maraki, Emmanouil Galanakis
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Infectious Disease Reports
Subjects:
Online Access:https://www.pagepress.org/journals/index.php/idr/article/view/7744
_version_ 1818979905657896960
author Eleni Vergadi
Antonia Manoura
Emmanouil Chatzakis
Emmanouil Karavitakis
Sofia Maraki
Emmanouil Galanakis
author_facet Eleni Vergadi
Antonia Manoura
Emmanouil Chatzakis
Emmanouil Karavitakis
Sofia Maraki
Emmanouil Galanakis
author_sort Eleni Vergadi
collection DOAJ
description Group B streptococcus (GBS) remains a leading cause of neonatal disease. However, GBS rates and prevention strategies vary considerably worldwide. Herein, we investigated the burden and epidemiological trends of neonatal GBS infections in our area (Greece) over the last two decades. We conducted a multicenter retrospective study that includes all cases of culture-proven GBS disease in infants <90 days old in the last 22 years. Neonatal GBS incidence was 0.17/1000 live births (95%CI: 0.11-0.21). A significant increase was noted during the second decade (0.23 vs 0.10/1000, P<0.05). Late onset disease (LOD) significantly increased during the second decade (0.08 vs 0.02, P<0.05). Infants in the LOD group had a higher risk of meningitis (RR 1.8, 95%CI: 1.23-2.71). Long-term neurological sequelae were reported in 42.8% of meningitis cases. The mortality rate was 8%. The incidence of neonatal GBS disease in our area is among the lowest reported, but an increase was noted the last decade mainly due a rise in the LOD. The burden of LOD, the mortality and long-term disability are still substantial, thus effective prevention strategies − including maternal vaccination for neonatal GBS − are needed.
first_indexed 2024-12-20T17:06:58Z
format Article
id doaj.art-b632eab6f3eb434eb6ee25b4c387a554
institution Directory Open Access Journal
issn 2036-7430
2036-7449
language English
last_indexed 2024-12-20T17:06:58Z
publishDate 2018-12-01
publisher MDPI AG
record_format Article
series Infectious Disease Reports
spelling doaj.art-b632eab6f3eb434eb6ee25b4c387a5542022-12-21T19:32:15ZengMDPI AGInfectious Disease Reports2036-74302036-74492018-12-0110310.4081/idr.2018.7744Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, GreeceEleni Vergadi0Antonia Manoura1Emmanouil Chatzakis2Emmanouil Karavitakis3Sofia Maraki4Emmanouil Galanakis5Department or Pediatrics, University of Crete, School of MedicineDepartment of Neonatology, Heraklion University HospitalDepartment of Neonatology, Venizeleion General HospitalDepartment of Neonatology, General Hospital of ChaniaDepartment of Clinical Microbiology, Heraklion University Hospital, CreteDepartment or Pediatrics, University of Crete, School of MedicineGroup B streptococcus (GBS) remains a leading cause of neonatal disease. However, GBS rates and prevention strategies vary considerably worldwide. Herein, we investigated the burden and epidemiological trends of neonatal GBS infections in our area (Greece) over the last two decades. We conducted a multicenter retrospective study that includes all cases of culture-proven GBS disease in infants <90 days old in the last 22 years. Neonatal GBS incidence was 0.17/1000 live births (95%CI: 0.11-0.21). A significant increase was noted during the second decade (0.23 vs 0.10/1000, P<0.05). Late onset disease (LOD) significantly increased during the second decade (0.08 vs 0.02, P<0.05). Infants in the LOD group had a higher risk of meningitis (RR 1.8, 95%CI: 1.23-2.71). Long-term neurological sequelae were reported in 42.8% of meningitis cases. The mortality rate was 8%. The incidence of neonatal GBS disease in our area is among the lowest reported, but an increase was noted the last decade mainly due a rise in the LOD. The burden of LOD, the mortality and long-term disability are still substantial, thus effective prevention strategies − including maternal vaccination for neonatal GBS − are needed.https://www.pagepress.org/journals/index.php/idr/article/view/7744neonatal infectionsGroup B streptococcusincidencelate onsetearly onsetintrapartum prophylaxis
spellingShingle Eleni Vergadi
Antonia Manoura
Emmanouil Chatzakis
Emmanouil Karavitakis
Sofia Maraki
Emmanouil Galanakis
Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
Infectious Disease Reports
neonatal infections
Group B streptococcus
incidence
late onset
early onset
intrapartum prophylaxis
title Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
title_full Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
title_fullStr Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
title_full_unstemmed Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
title_short Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
title_sort changes in the incidence and epidemiology of neonatal group b streptococcal disease over the last two decades in crete greece
topic neonatal infections
Group B streptococcus
incidence
late onset
early onset
intrapartum prophylaxis
url https://www.pagepress.org/journals/index.php/idr/article/view/7744
work_keys_str_mv AT elenivergadi changesintheincidenceandepidemiologyofneonatalgroupbstreptococcaldiseaseoverthelasttwodecadesincretegreece
AT antoniamanoura changesintheincidenceandepidemiologyofneonatalgroupbstreptococcaldiseaseoverthelasttwodecadesincretegreece
AT emmanouilchatzakis changesintheincidenceandepidemiologyofneonatalgroupbstreptococcaldiseaseoverthelasttwodecadesincretegreece
AT emmanouilkaravitakis changesintheincidenceandepidemiologyofneonatalgroupbstreptococcaldiseaseoverthelasttwodecadesincretegreece
AT sofiamaraki changesintheincidenceandepidemiologyofneonatalgroupbstreptococcaldiseaseoverthelasttwodecadesincretegreece
AT emmanouilgalanakis changesintheincidenceandepidemiologyofneonatalgroupbstreptococcaldiseaseoverthelasttwodecadesincretegreece